Rigor Reviewed

Rigor-Reviewed Manuscript

Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial.

Name: Αlpha¹ Rigor Record — Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial.
Item: Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial.
Rating: 94
Author: Αlpha¹

Rahman A, Malik A, Nazir H, Zaidi A, Nisar A, Waqas A, Atif N, Gibbs NK, Luo Y, Sikander S, Wang D

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 2★ (Weak), 0 critical, 4 high issues for “Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

2 / 5

Weak — serious problems found

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×3−1.5★
ClaimsOverstated claim−0.5★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ReportingData & code availability partially met−0.25★
LinksDead data/code link−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Problems surfaced7 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions3

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Conclusions overstated beyond the evidenceAssessed
Conclusions only partially backed by the presented evidenceAssessed

Data authenticity concerns1

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Other integrity concernAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed

Broken references and links1

References checked against Crossref, OpenAlex and Retraction Watch for retractions and resolvability, plus declared data and code links probed for whether they resolve to content matching the paper.

Dead data/code linksRecomputed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-conducted and well-reported cluster-randomized noninferiority trial with a strong scientific premise, rigorous design, and transparent reporting. The main weakness is the data/code availability: the repository link is dead and the access route is vague, which undermines reproducibility. Minor reporting gaps include incomplete identification of the THP-TAP app and lack of explicit outlier handling.

Both reviewers classified the study as interventional (cluster-randomized trial), and I adopt that classification. The evaluation covered all eight dimensions; species/strain, housing, antibodies, cell lines, and mycoplasma testing were not applicable as this is a human trial. The statistics verification recomputed only 3 tests (all consistent); the remaining statistics are unverified. The citation check found no retracted or unresolved references.

5 major claims checked against the paper's own evidence: 1 not fully backed by the presented evidence (unsupported or overstated), 1 only partially supported (evidence backs part of the claim; gaps or caveats remain).

Premise concern: surrogate not validated for clinical benefit.

Recomputed 3 tests: 3 consistent, 0 inconsistent; 3 via agent-written checks.

3 integrity concerns flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites a systematic review and IPD meta-analysis of task-shared psychological interventions, the original THP trial, and WHO adoption, acknowledging both strengths and limitations (e.g., 'voltage-drop', 'program drift', critiques of reductionism). The rationale for the noninferiority design and the choice of margin are explicitly justified. The paper also addresses limitations of prior work by describing how peer delivery and digital assistance aim to overcome quality and fidelity issues.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a strong scientific premise by citing prior research on the burden of perinatal depression, the effectiveness of task-shared interventions, and the specific challenges of scaling up WHO-THP, leading to a clear rationale for the new intervention.

Evidence

direct quote[Introduction, paragraph 3]

“A systematic literature review and individual patient data meta-analysis of 11 trials of 4,145 participants from LMICs showed that task-shared psychological interventions for depression were associated with a greater decrease in symptom severity than control conditions”